The fundamental purpose of the IRB is for the protection of human subjects in research. The IRB committee reviews and monitors research projects according to federal regulations. The IRB also assists in the education of those involved in research. A Clinical Research Newsletter (CRN) was developed as an educational outreach source for professional staff and employees. The CRN is generated monthly with featured articles of continued education and newly approved research projects.
Cleveland Clinic's Institutional Review Board consists of members including both staff-level and resident physicians, administrative personnel, nursing personnel, and non-affiliated lay people to represent the community. Continual development of IRB studies ensures the highest possible standard of health care for patients in South Florida.
Institutional Review Board
Cleveland Clinic Foundation
9500 Euclid Avenue
Cleveland, OH 44195
IRB Chairman: Alan Lichtin, MD
Executive Director: Daniel Beyer, MS, MHA, CIP
Frequency of IRB meetings: Weekly
Day of IRB convened meeting: Fridays
Deadline of research submissions: By 5 pm Wednesday for review the following week on Friday
Timeframe for IRB approval letter: 2-3 business days after the convened IRB meeting.
Scope of Review
IRB review is required for any research involving human subjects.